The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Molecular genetics and clinical features of Birt–Hogg–Dubé syndrome
Open accessAbstract
Birt–Hogg–Dubé (BHD) syndrome is an inherited renal cancer syndrome in which affected individuals are at risk of developing benign cutaneous fibrofolliculomas, bilateral pulmonary cysts and spontaneous pneumothoraces, and kidney tumours. Bilateral multifocal renal tumours that develop in BHD syndrome are most frequently hybrid oncocytic tumours and chromophobe renal carcinoma, but can present with other histologies. Germline mutations in the FLCN gene on chromosome 17 are responsible for BHD syndrome—BHD-associated renal tumours display inactivation of the wild-type FLCN allele by somatic mutation or chromosomal loss, confirming that FLCN is a tumour suppressor gene that fits the classic two-hit model. FLCN interacts with two novel proteins, FNIP1 and FNIP2, and with AMPK, a negative regulator of mTOR. Studies with FLCN-deficient cell and animal models support a role for FLCN in modulating the AKT–mTOR pathway. Emerging evidence links FLCN with a number of other molecular pathways and cellular processes important for cell homeostasis that are frequently deregulated in cancer, including regulation of TFE3 and/or TFEB transcriptional activity, amino-acid-dependent mTOR activation through Rag GTPases, TGFβ signalling, PGC1α-driven mitochondrial biogenesis, and autophagy. Currently, surgical intervention is the only therapy available for BHD-associated renal tumours, but improved understanding of the FLCN pathway will hopefully lead to the development of effective forms of targeted systemic therapy for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Self-citationThe Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Self-citationRoczniak-Ferguson, A., Petit, C. S., Froehlich, F., Qian, S., Ky, J., Angarola, B., Walther, T. C., & Ferguson, S. M. (2012) · Science Signaling · doi:10.1126/scisignal.2002790 · Cited by 1,366
Integrated molecular analysis of clear-cell renal cell carcinoma
Sato, Y., Yoshizato, T., Shiraishi, Y., Maekawa, S., Okuno, Y., Kamura, T., Shimamura, T., Sato-Otsubo, A., Nagae, G., Suzuki, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2699 · Cited by 1,221
Nickerson, M. L., Warren, M. B., Toro, J. R., Matrosova, V., Glenn, G., Turner, M. L., Duray, P., Merino, M., Choyke, P., Pavlovich, C. P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00104-6 · Cited by 940
Self-citationThe Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Davis, C. F., Ricketts, C. J., Wang, M., Yang, L., Cherniack, A. D., Shen, H., Buhay, C., Kang, H., Kim, S. C., Fahey, C. C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.014 · Cited by 842
Self-citationHereditary Multiple Fibrofolliculomas With Trichodiscomas and Acrochordons
Birt, A. R. (1977) · Archives of Dermatology · doi:10.1001/archderm.113.12.1674 · Cited by 797
Regulation of mTORC1 by amino acids
Bar-Peled, L., & Sabatini, D. M. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.03.003 · Cited by 773
The genetic basis of kidney cancer: a metabolic disease
Linehan, W. M., Srinivasan, R., & Schmidt, L. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.47 · Cited by 744
Self-citationLKB1 and AMP-activated protein kinase control of mTOR signalling and growth
Shaw, R. J. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01972.x · Cited by 644
Renal Tumors in the Birt-Hogg-Dubé Syndrome
Pavlovich, C. P., Walther, M. M., Eyler, R. A., Hewitt, S. M., Zbar, B., Linehan, W. M., & Merino, M. J. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200212000-00002 · Cited by 604
Self-citationBirt-Hogg-Dubé syndrome: diagnosis and management
Menko, F. H., van Steensel, M. A., Giraud, S., Friis-Hansen, L., Richard, S., Ungari, S., Nordenskjöld, M., Hansen, T. V., Solly, J., & Maher, E. R. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70188-3 · Cited by 590
Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
Nickerson, M. L., Jaeger, E., Shi, Y., Durocher, J. A., Mahurkar, S., Zaridze, D., Matveev, V., Janout, V., Kollarova, H., Bencko, V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4921 · Cited by 588
Self-citationTsun, Z.-Y., Bar-Peled, L., Chantranupong, L., Zoncu, R., Wang, T., Kim, C., Spooner, E., & Sabatini, D. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.016 · Cited by 565
Toro, J. R., Wei, M.-H., Glenn, G. M., Weinreich, M., Toure, O., Vocke, C., Turner, M., Choyke, P., Merino, M. J., Pinto, P. A., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.054304 · Cited by 513
Self-citationBaba, M., Hong, S.-B., Sharma, N., Warren, M. B., Nickerson, M. L., Iwamatsu, A., Esposito, D., Gillette, W. K., Hopkins, R. F., Hartley, J. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603781103 · Cited by 491
Self-citationSchmidt, L. S., Nickerson, M. L., Warren, M. B., Glenn, G. M., Toro, J. R., Merino, M. J., Turner, M. L., Choyke, P. L., Sharma, N., Peterson, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/430842 · Cited by 405
Self-citationBirt-Hogg-Dubé Syndrome: A Novel Marker of Kidney Neoplasia
Toro, J. R., Glenn, G. M., Duray, P. H., Darling, T. N., Weirich, G., Zbar, B., Linehan, W. M., & Turner, M. L. C. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.10.1195 · Cited by 373
Self-citationSchmidt, L. S., Warren, M. B., Nickerson, M. L., Weirich, G., Matrosova, V., Toro, J. R., Turner, M. L., Duray, P., Merino, M., Hewitt, S., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323744 · Cited by 365
Self-citationRecruitment of folliculin to lysosomes supports the amino acid–dependent activation of Rag GTPases
Petit, C. S., Roczniak-Ferguson, A., & Ferguson, S. M. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201307084 · Cited by 355
Betschinger, J., Nichols, J., Dietmann, S., Corrin, P. D., Paddison, P. J., & Smith, A. (2013) · Cell · doi:10.1016/j.cell.2013.03.012 · Cited by 342
Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation.
Jamis-Dow, C. A., Choyke, P. L., Jennings, S. B., Linehan, W. M., Thakore, K. N., & Walther, M. M. (1996) · Radiology · doi:10.1148/radiology.198.3.8628872 · Cited by 311
Self-citationBaba, M., Furihata, M., Hong, S.-B., Tessarollo, L., Haines, D. C., Southon, E., Patel, V., Igarashi, P., Alvord, W. G., Leighty, R., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm288 · Cited by 258
Self-citationHigh Frequency of Somatic Frameshift BHD Gene Mutations in Birt-Hogg-Dubé–Associated Renal Tumors
Vocke, C. D., Yang, Y., Pavlovich, C. P., Schmidt, L. S., Nickerson, M. L., Torres-Cabala, C. A., Merino, M. J., Walther, M. M., Zbar, B., & Linehan, W. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji154 · Cited by 241
Self-citationHasumi, Y., Baba, M., Ajima, R., Hasumi, H., Valera, V. A., Klein, M. E., Haines, D. C., Merino, M. J., Hong, S.-B., Yamaguchi, T. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908853106 · Cited by 232
Self-citationThe role of the Birt–Hogg–Dubé protein in mTOR activation and renal tumorigenesis
Hartman, T. R., Nicolas, E., Klein-Szanto, A., Al-Saleem, T., Cash, T. P., Simon, M. C., & Henske, E. P. (2009) · Oncogene · doi:10.1038/onc.2009.14 · Cited by 215
Clinical and genetic studies of Birt-Hogg-Dubé syndrome
Khoo, S. K., Giraud, S., Kahnoski, K., Chen, J., Motorna, O., Nickolov, R., Binet, O., Lambert, D., Friedel, J., Lévy, R., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.12.906 · Cited by 215
Lingaas, F. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg336 · Cited by 192
Identification and characterization of a novel folliculin-interacting protein FNIP2
Hasumi, H., Baba, M., Hong, S.-B., Hasumi, Y., Huang, Y., Yao, M., Valera, V. A., Linehan, W. M., & Schmidt, L. S. (2008) · Gene · doi:10.1016/j.gene.2008.02.022 · Cited by 191
Self-citationHong, S.-B., Oh, H., Valera, V. A., Baba, M., Schmidt, L. S., & Linehan, W. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015793 · Cited by 183
Self-citationGasparre, G., Hervouet, É., de Laplanche, E., Demont, J., Pennisi, L. F., Colombel, M. C., Mège‐Lechevallier, F., Scoazec, J., Bonora, E., Smeets, R., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm371 · Cited by 156
Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia
Chen, J., Futami, K., Petillo, D., Peng, J., Wang, P., Knol, J., Li, Y., Khoo, S. K., Huang, D., Qian, C.-N., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003581 · Cited by 153
Medvetz, D. A., Khabibullin, D., Hariharan, V., Ongusaha, P. P., Goncharova, E. A., Schlechter, T., Darling, T. N., Hofmann, I., Krymskaya, V. P., Liao, J. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047842 · Cited by 153
Inactivation of BHD in sporadic renal tumors.
Khoo, S. K., Kahnoski, K., Sugimura, J., Petillo, D., Chen, J., Shockley, K., Ludlow, J. W., Knapp, R., Giraud, S., Richard, S., et al. (2003) · PubMed · Cited by 143
The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation
Yan, M., Gingras, M., Dunlop, E. A., Nouët, Y., Dupuy, F., Jalali, Z., Possik, E., Coull, B. J., Kharitidi, D., Dydensborg, A. B., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71749 · Cited by 141
Takagi, Y., Kobayashi, T., Shiono, M., Wang, L., Piao, X., Sun, G., Zhang, D., Abe, M., Hagiwara, Y., Takahashi, K., et al. (2008) · Oncogene · doi:10.1038/onc.2008.261 · Cited by 135
Pulmonary manifestations of Birt-Hogg-Dubé syndrome
Gupta, N., Seyama, K., & McCormack, F. X. (2013) · Familial Cancer · doi:10.1007/s10689-013-9660-9 · Cited by 122
Renal tumour suppressor function of the Birt–Hogg–Dubé syndrome gene product folliculin
Hudon, V., Sabourin, S., Dydensborg, A. B., Kottis, V., Ghazi, A., Paquet, M., Crosby, K., Pomerleau, V., Uetani, N., & Pause, A. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.072009 · Cited by 121
Folliculin Regulates Ampk-Dependent Autophagy and Metabolic Stress Survival
Possik, E., Jalali, Z., Nouët, Y., Yan, M., Gingras, M., Schmeißer, K., Panaite, L., Dupuy, F., Kharitidi, D., Chotard, L., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004273 · Cited by 121
A new locus-specific database (LSDB) for mutations in the folliculin (FLCN) gene
Lim, D. H. K., Rehal, P. K., Nahorski, M. S., et al. (2009) · Human Mutation · doi:10.1002/humu.21130 · Cited by 116
Regulation of Mitochondrial Oxidative Metabolism by Tumor Suppressor FLCN
Hasumi, H., Baba, M., Hasumi, Y., Huang, Y. K., Oh, H., Hughes, R. M., Klein, M. E., Takikita, S., Nagashima, K., Schmidt, L. S., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs418 · Cited by 108
Self-citationCrystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer
Nookala, R. K., Langemeyer, L., Pacitto, A., Ochoa-Montaño, B., Donaldson, J. C., Blaszczyk, B. K., Chirgadze, D. Y., Barr, F. A., Bazan, J. F., & Blundell, T. L. (2012) · Open Biology · doi:10.1098/rsob.120071 · Cited by 106
Goncharova, E. A., Goncharov, D. A., James, M. L., Atochina‐Vasserman, E. N., Stepanova, V. V., Hong, S., Li, H., Gonzales, L. K., Baba, M., Linehan, W. M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.025 · Cited by 99
Self-citationHong, S., Oh, H., Valera, V., Stull, J., Ngo, D.-T., Baba, M., Merino, M. J., Linehan, W. M., & Schmidt, L. S. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-160 · Cited by 99
Self-citationDisruption of Fnip1 Reveals a Metabolic Checkpoint Controlling B Lymphocyte Development
Park, H., Staehling‐Hampton, K., Tsang, M., Appleby, M. W., Brunkow, M. E., Margineantu, D. H., Hockenbery, D. M., Habib, T., Liggitt, D., Carlson, G. A., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.02.019 · Cited by 98
Hasumi, H., Baba, M., Hasumi, Y., Lang, M., Huang, Y. K., Oh, H., Matsuo, M., Merino, M. J., Yao, M., Ito, Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419502112 · Cited by 96
Self-citationNahorski, M. S., Lim, D., Martin, L. M., Gille, J. J. P., Bounford, K. M., Rehal, P. K., Ploeger, H. M., Steensel, M. A. M. V., Tomlinson, I. P. M., Latif, F., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.073304 · Cited by 95
Okimoto, K., Sakurai, J., Kobayashi, T., Mitani, H., Hirayama, Y., Nickerson, M. L., Warren, M. B., Zbar, B., Schmidt, L. S., & Hino, O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308071100 · Cited by 94
Self-citationFLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation
Dunlop, E. A., Seifan, S., Claessens, T., Behrends, C., Kamps, M. A. F., Rozycka, E., Kemp, A. J., Nookala, R. K., Blenis, J., Coull, B. J., et al. (2014) · Autophagy · doi:10.4161/auto.29640 · Cited by 92
Klomp, J. A., Petillo, D., Niemi, N. M., Dykema, K. J., Chen, J., Yang, X. J., Sääf, A. M., Zickert, P., Aly, M., Bergerheim, U. S. R., et al. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-59 · Cited by 91
van Slegtenhorst, M., Khabibullin, D., Hartman, T. R., Nicolas, É., Kruger, W. D., & Henske, E. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700857200 · Cited by 81
The armadillo protein p0071 regulates Rho signalling during cytokinesis
Wolf, A., Keil, R., Götzl, O., Mun, A., Schwarze, K., Lederer, M., Hüttelmaier, S., & Hatzfeld, M. (2006) · Nature Cell Biology · doi:10.1038/ncb1504 · Cited by 80
da Silva, N. F., Gentle, D., Hesson, L. B., Morton, D. G., Latif, F., & Maher, E. R. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.11.820 · Cited by 73
Baba, M., Keller, J. R., Sun, H., Resch, W., Kuchen, S., Suh, H. C., Hasumi, H., Hasumi, Y., Kieffer-Kwon, K.-R., Gallego, C., et al. (2012) · Blood · doi:10.1182/blood-2012-02-410407 · Cited by 72
Self-citationPreston, R. S., Philp, A., Claessens, T., Gijezen, L., Dydensborg, A. B., Dunlop, E. A., Harper, K., Brinkhuizen, T., Menko, F. H., Davies, D. M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.497 · Cited by 72
Cash, T. P., Gruber, J. J., Hartman, T. R., Henske, E. P., & Simon, M. C. (2011) · Oncogene · doi:10.1038/onc.2010.628 · Cited by 71
Identification of intragenic deletions and duplication in the FLCN gene in Birt‐Hogg‐Dubé syndrome
Benhammou, J. N., Vocke, C. D., Santani, A., Schmidt, L. S., Baba, M., Seyama, K., Wu, X., Korolevich, S., Nathanson, K. L., Stolle, C. A., et al. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20872 · Cited by 66
Self-citationFolliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation
Hasumi, Y., Baba, M., Hasumi, H., Huang, Y. K., Lang, M., Reindorf, R., Oh, H., Sciarretta, S., Nagashima, K., Haines, D. C., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu286 · Cited by 66
Self-citationKhabibullin, D., Medvetz, D. A., Pinilla-Vera, M., Hariharan, V., Li, C., Hergrueter, A., Laucho-Contreras, M. E., Zhang, E. Y., Parkhitko, A. A., Yu, J. J., et al. (2014) · Physiological Reports · doi:10.14814/phy2.12107 · Cited by 60
The UOK 257 cell line: a novel model for studies of the human Birt–Hogg–Dubé gene pathway
Yang, Y., Padilla‐Nash, H. M., Vira, M. A., et al. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.10.010 · Cited by 59
Nahorski, M. S., Seabra, L., Straatman-Iwanowska, A. A., Wingenfeld, A., Reiman, A., Lü, X., Klomp, J. A., Teh, B. T., Hatzfeld, M., Gissen, P., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds378 · Cited by 58
Identification and characterization of Birt–Hogg–Dubé associated renal carcinoma
Murakami, T., Sano, F., Huang, Y. K., Komiya, A., Baba, M., Osada, Y., Nagashima, Y., Kondo, K., Nakaigawa, N., Miura, T., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2139 · Cited by 52
Nagy, A., Zoubakov, D., Stupar, Z., & Kovács, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.11694 · Cited by 49
Pradella, L. M., Lang, M., Kurelac, I., Mariani, E., Guerra, F., Zuntini, R., Tallini, G., Mackay, A. G., Reis-Filho, J. S., Seri, M., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.8 · Cited by 28
Serine 62 is a phosphorylation site in folliculin, the Birt–Hogg–Dubé gene product
Wang, L., Kobayashi, T., Piao, X., Shiono, M., Takagi, Y., Mineki, R., Taka, H., Zhang, D., Abe, M., Sun, G., et al. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.11.033 · Cited by 25
Birt–Hogg–Dubé syndrome and the skin
Vernooij, M., Claessens, T., Luijten, M., Steensel, M. A. M. V., & Coull, B. J. (2013) · Familial Cancer · doi:10.1007/s10689-013-9600-8 · Cited by 22
A novel protein, MAPO1, that functions in apoptosis triggered by O6-methylguanine mispair in DNA
Komori, K., Takagi, Y., Sanada, M., Lim, T.-H., Nakatsu, Y., Tsuzuki, T., Sekiguchi, M., & Hidaka, M. (2009) · Oncogene · doi:10.1038/onc.2008.462 · Cited by 15
Lü, X., Boora, U., Seabra, L., Rabai, E., Fenton, J., Reiman, A., Nagy, Z., & Maher, E. R. (2013) · Oncogene · doi:10.1038/onc.2013.27 · Cited by 13
Cited by
Puertollano, R., Ferguson, S. M., Brugarolas, J., & Ballabio, A. (2018) · The EMBO Journal · doi:10.15252/embj.201798804 · Cited by 531
TFEB and TFE3: Linking Lysosomes to Cellular Adaptation to Stress
Raben, N., & Puertollano, R. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125407 · Cited by 437
A substrate-specific mTORC1 pathway underlies Birt–Hogg–Dubé syndrome
Napolitano, G., Di Malta, C., Esposito, A., de Araujo, M. E. G., Pece, S., Bertalot, G., Matarese, M., Benedetti, V., Zampelli, A., Stasyk, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2444-0 · Cited by 341
The Metabolic Basis of Kidney Cancer
Linehan, W. M., Schmidt, L. S., Crooks, D. R., Wei, D., Srinivasan, R., Lang, M., & Ricketts, C. J. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1354 · Cited by 306
Self-citationLysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology
Settembre, C., & Perera, R. M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00676-x · Cited by 285
Metadata
- Authors
- Schmidt, L. S., & Linehan, W. M.
- Venue
- Nature Reviews Urology
- Published
- 2015-09-01
- Volume
- 12
- Issue
- 10
- Pages
- 558-569
- ISSN
- 1759-4812 (ISSN-L)
- 1759-4820
- OpenAlex
- W2247166227
- Cited by
- 255
- References
- 72
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.